Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ag.Cl |
Molecular Weight | 143.321 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Ag+]
InChI
InChIKey=HKZLPVFGJNLROG-UHFFFAOYSA-M
InChI=1S/Ag.ClH/h;1H/q+1;/p-1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Ag |
Molecular Weight | 107.8682 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966Bhttps://www.ncbi.nlm.nih.gov/pubmed/19278981https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738Curator's Comment: description was created based on several sources, including
https://www.drugs.com/monograph/silver-nitrate.html |
https://www.ncbi.nlm.nih.gov/pubmed/18245232
Sources: https://www.purebio.com/assets/001/5202.pdfhttp://google.com/patents/CN102923966Bhttps://www.ncbi.nlm.nih.gov/pubmed/19278981https://www.ncbi.nlm.nih.gov/pubmed/26897901https://www.ncbi.nlm.nih.gov/pubmed/25781988The legal airborne permissible exposure limit (PEL) is 11 mg/m^2 averaged over an 8-hour workshift.https://www.ncbi.nlm.nih.gov/pubmed/20429870https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2930 | https://www.ncbi.nlm.nih.gov/pubmed/11294738
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/monograph/silver-nitrate.html |
https://www.ncbi.nlm.nih.gov/pubmed/18245232
Silver iodide is an inorganic compound with the formula AgI. It is used as a photosensitive agent in photography, as a local antiseptic, as a chemical intermediate, and in cloud seeding for rain-making. The major hazards encountered in the use and handling of silver iodide stem from its toxicologic properties. Effects from exposure may include skin rashes, conjunctivitis, argyria (a permanent ashen-gray discoloration of skin, conjunctiva, and internal organs), headache, fever, hypersensitivity, laryngitis, and bronchitis.
Originator
Sources: Vestsi Akademii Navuk BSSR, Seryya Khimichnykh Navuk, Issue 2, Pages 69-73, Journal, 1990https://www.ncbi.nlm.nih.gov/pubmed/20429870
Curator's Comment: The medical uses of silver date back to at least the time of Hippocrates
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26897901 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0034505 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24373700 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
|||
Target ID: GO:0071292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18245232 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Advantage Arrest Silver Diamine Fluoride Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Curative | Unknown Approved UseUnknown |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Primary | Colloidal silver iodide Approved UseSolution containing 5 to 49% of colloidal silver iodide have been employed in the treatment of infections of the mucous membranes. Ointments, usually containing 5%, have been used in inflammatory conditions of the eye, ear, and nose. |
|||
Palliative | Unknown Approved UseAntiseptic Wound Cauterization |
|||
Primary | Unknown Approved UseProphylaxis of gonococcal ophthalmia neonatorum. AAP recommends use of topical silver nitrate, povidone-iodine, or possibly erythromycin for prophylaxis of nongonococcal nonchlamydial conjunctivitis in neonates, ideally administered shortly after birth. |
PubMed
Title | Date | PubMed |
---|---|---|
Lack of genotoxicity of silver iodide in the SCE assay in vitro, in vivo, and in the Ames/microsome test. | 1998 |
|
A chemically intelligent antimicrobial coating for urologic devices. | 2000 Feb |
|
Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. | 2005 Mar |
|
Photocatalytic degradation of pathogenic bacteria with AgI/TiO2 under visible light irradiation. | 2007 Apr 24 |
|
Topical antimicrobials for burn wound infections. | 2010 Jun |
|
Development of silica-coated silver iodide nanoparticles and their biodistribution. | 2012 Dec |
|
A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione. | 2014 Apr 22 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.purebio.com/assets/001/5202.pdf
Curator's Comment: Toxicity data
Topical as a 1:80 dilution (30 ppm ionic silver).
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27775827
10 mkl volume of undiluted human norovirus 20% faecal suspension was mixed with 90 mkl of SDC (Silver Dihydrogen Citrate) for various contact times (15, 30, 60, 120, 300, 600 and 1800 s). At each sampling time point, 20 mkl of this solution was added to 180 mkl of 10% solution of Dey/Engley (D/E) neutralizing broth (Thermo Fisher Scientific, Waltham, MA). Samples were aliquoted and frozen at -80°C prior to nucleic acid extraction.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:13:41 GMT 2023
by
admin
on
Fri Dec 15 16:13:41 GMT 2023
|
Record UNII |
MWB0804EO7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 310.548
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
||
|
EPA PESTICIDE CODE |
72506
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000078593
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
MWB0804EO7
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
1314846
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
m9918
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
7783-90-6
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
30341
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
C037548
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
24561
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
SUB15245MIG
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
232-033-3
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
DTXSID4035251
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
MWB0804EO7
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY | |||
|
SILVER CHLORIDE
Created by
admin on Fri Dec 15 16:13:41 GMT 2023 , Edited by admin on Fri Dec 15 16:13:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |